Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
N
|
Nikkiso Co Ltd
XMUN:NKO
|
JP |
|
H
|
Hitachi Construction Machinery Co Ltd
F:HCM
|
JP |
|
B
|
BAE Systems PLC
F:BSP
|
UK |
|
Staffline Group PLC
LSE:STAF
|
UK |
|
Aedifica NV
F:AOO
|
BE |
|
M
|
Marston's PLC
F:WVDA
|
UK |
|
N
|
Novo Nordisk A/S
DUS:NOVA
|
DK |
|
Kbc Groep NV
F:KDB0
|
BE |
|
T
|
Thai Rung Union Car PCL
SET:TRU
|
TH |
|
B
|
Build-A-Bear Workshop Inc
F:FPW
|
US |
|
P
|
Pharmx Technologies Ltd
ASX:PHX
|
AU |
|
I
|
Illumina Inc
XMUN:ILU
|
US |
|
Avant Brands Inc
TSX:AVNT
|
CA |
|
I
|
International Petroleum Corp
TSX:IPCO
|
CA |
|
Halliburton Co
NYSE:HAL
|
US |
|
N
|
North East Rubber PCL
SET:NER
|
TH |
|
Ebara Jitsugyo Co Ltd
F:EJI
|
JP |
|
F
|
Fortescue Ltd
XMUN:FVJ
|
AU |
|
T
|
Tosoh Corp
XMUN:TOS
|
JP |
|
A
|
Albis Leasing AG
F:ALG
|
DE |
|
Also Holding AG
F:9AS
|
CH |
|
AtriCure Inc
NASDAQ:ATRC
|
US |
|
Nissan Chemical Corp
TSE:4021
|
JP |
Intrinsic Value
Is TEVA undervalued or overvalued?
See the intrinsic value estimate for 
Teva Pharmaceutical Industries Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
TEVA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with TEVA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Teva Pharmaceutical Industries Does
Teva Pharmaceutical Industries is a global drug company best known for making generic medicines, which are lower-cost versions of branded drugs after patent protection ends. It also sells a smaller portfolio of branded specialty medicines, with a focus on treatments for the nervous system, breathing problems, and other chronic conditions. Its products are sold to pharmacies, hospitals, doctors, governments, and health systems around the world.
- Headquarters
- Israel IL
- Employees
- 31 173
- IPO date
- Jan 1, 1951
Teva Pharmaceutical Industries has no economic moat
Rival manufacturers can offer alternatives to many of Teva’s medicines, giving large drug buyers room to demand lower prices or choose another supplier. Patents protect some branded treatments, but do not keep competitors away from enough of Teva’s business to provide lasting protection overall.
Read the full moat analysis
Revenue & Expenses Breakdown
Teva Pharmaceutical Industries Ltd
Earnings Waterfall
Teva Pharmaceutical Industries Ltd
The intrinsic value for Teva Pharmaceutical Industries Ltd (TEVA) under the Base Case is hidden USD.
Compared with the current market price of 40.425 USD, the stock appears hidden.